Literature DB >> 7635989

Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity.

D M Foley1, R J Gayek, J T Skare, E A Wagar, C I Champion, D R Blanco, M A Lovett, J N Miller.   

Abstract

Erythema migrans (EM), persistent skin infection, and visceral dissemination can be induced reproducibly in the adult male New Zealand White rabbit by intradermal injection of as few as 10(3) Borrelia burgdorferi. EM was found to persist for 7 +/- 3 d. Skin culture positivity (infection) cleared within a mean of 6.7 +/- 1.4 wk after infection and similarly visceral infection was not demonstrated after 8 wk; infection-derived immunity to intradermal challenge was evident 5 mo after initial infection. The extent of the protection against EM and dermal infection induced by untreated infection was directly related to the extent of prior in vitro passage of the B31 strain. Initial infection with as few as 4 x 10(3) B31 passage 4 induced complete protection against EM and skin infection upon subsequent challenge with 4 x 10(7) B31, passage 4. Initial infection with B31 passage 27 led to partial protection against EM along with complete protection against skin infection. Initial infection with passage 47 led to partial protection against EM, but conferred no protection against skin infection. Using serum from rabbits fully immune to reinfection, we defined a set of B. burgdorferi proteins present in virulent B31, but absent in the avirulent American Type Culture Collection B31 strain, termed "va" for virulent strain associated. The va proteins of B31 passages 1, 27, and 47 differed strikingly, thus raising the possibility that these changes may relate in a causal way to the differences in induction of protective immunity observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635989      PMCID: PMC185284          DOI: 10.1172/JCI118144

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

4.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

5.  Ixodes dammini: induced skin lesions in guinea pigs and rabbits compared to erythema chronicum migrans in patients with lyme arthritis.

Authors:  W L Krinsky; S J Brown; P W Askenase
Journal:  Exp Parasitol       Date:  1982-06       Impact factor: 2.011

6.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

7.  A guinea pig model for Lyme disease.

Authors:  S W Sonnesyn; J C Manivel; R C Johnson; J L Goodman
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Chronic Lyme borreliosis in the laboratory mouse.

Authors:  S W Barthold; M S de Souza; J L Janotka; A L Smith; D H Persing
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Authors:  B Wilske; V Preac-Mursic; U B Göbel; B Graf; S Jauris; E Soutschek; E Schwab; G Zumstein
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more
  24 in total

1.  PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.

Authors:  R K Straubinger
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

3.  Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorferi.

Authors:  J T Skare; D M Foley; S R Hernandez; D C Moore; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.

Authors:  E S Shang; C I Champion; X Y Wu; J T Skare; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity.

Authors:  D M Foley; Y P Wang; X Y Wu; D R Blanco; M A Lovett; J N Miller
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.

Authors:  M S Hanson; D R Cassatt; B P Guo; N K Patel; M P McCarthy; D W Dorward; M Höök
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes.

Authors:  Brian Stevenson; Nazira El-Hage; Melissa A Hines; Jennifer C Miller; Kelly Babb
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Virulent strain associated outer membrane proteins of Borrelia burgdorferi.

Authors:  J T Skare; E S Shang; D M Foley; D R Blanco; C I Champion; T Mirzabekov; Y Sokolov; B L Kagan; J N Miller; M A Lovett
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin.

Authors:  Timothy R Crother; Cheryl I Champion; Julian P Whitelegge; Rodrigo Aguilera; Xiao-Yang Wu; David R Blanco; James N Miller; Michael A Lovett
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Evidence for strain-specific immunity in patients treated for early lyme disease.

Authors:  Camilo E Khatchikian; Robert B Nadelman; John Nowakowski; Ira Schwartz; Gary P Wormser; Dustin Brisson
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.